Home
About
FAQ
History (3)
Botulinum toxin for the treatment of movement disorders.
Non homologous end joining-mediated DNA break repair is impaired in B lymphocytes of aging mice.
Patient-Surgeon Relationship Influences Outcomes in Bariatric Patients.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Botulinum toxin for the treatment of movement disorders.
Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep. 2012 Aug; 12(4):399-409.
View in:
PubMed
subject areas
Animals
Blepharospasm
Botulinum Toxins
Hemifacial Spasm
Humans
Movement Disorders
Treatment Outcome
authors with profiles
Mary Ann Thenganatt MD